IL-1RA is an acute-phase marker, and high levels have previously been associated with aggressive disease and/or unfavorable prognosis in various malignancies, including T-cell lymphoma [48], sarcoma [49], colorectal cancer [50,51], and thyroid cancer [52]. This evidence concerns the gene IL6R and thyroid cancer.